Company Filing History:
1 out of 56 
1 out of 87 
1 out of 1 Years Active: 2025
Title: Claudia Daubenberger: Innovator in Malaria Vaccine Development
Introduction
Claudia Daubenberger is a prominent inventor based in Mülheim, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of vaccines for malaria. Her innovative work has the potential to impact global health positively.
Latest Patents
Claudia Daubenberger holds 1 patent related to her research. The patent focuses on Plasmodium sporozoite NPDP peptides as a target for novel malaria vaccines and antibodies. The invention provides a fragment of the plasmodium circumsporozoite protein, which can be utilized in malaria vaccine development. Additionally, it includes nucleic acids encoding this protein fragment and compositions that comprise it. The antibodies developed from this invention specifically bind to sporozoites, offering potential applications in the treatment and prevention of malaria.
Career Highlights
Throughout her career, Claudia has worked at esteemed institutions such as the Institute for Research in Biomedicine and Seattle Children's Hospital. Her research has been pivotal in advancing our understanding of malaria and developing effective vaccines.
Collaborations
Claudia has collaborated with notable scientists, including Antonio Lanzavecchia and Joshua Hoong Yu Tan. These partnerships have enriched her research and contributed to the advancement of malaria vaccine development.
Conclusion
Claudia Daubenberger's innovative work in malaria vaccine research exemplifies her commitment to improving global health. Her contributions through patents and collaborations highlight her role as a leading inventor in the field.